Breast cancer (malignant breast neoplasm) is a type of cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk.

• Gian Paolo Andreoletti

  Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer http://www.nature.com/bjc/journal/vaop/ncurrent/full/bjc201232a.html
• Somisetty Swathi

  Basing on the size of the lump in the mammography image we can conclude the stage of the cancer?

  Basing on the mammography images the lump was seen in the images with that the size of the lump will measure by the image processing technique in the Artificial neural network we can conclude theBasing on the mammography images the lump was seen in the images with that the size of the lump will measure by the image processing technique in the Artificial neural network we can conclude the stage of breast cancer.. bcoz i studied that basing on the size lump the stage of the breast cancer will detected is it correct suggest me plz
• Somisetty Swathi

  Is there any software method to detect breast cancer in early stage?

  presently mammogram was using to detect the breast cancer, but there is any technique in ARTIFICIAL NEURAL NETWORK using to detect the breast cancer

  Recent replies ⋅ Show All (22)

  • 
    Debomita Sengupta replied

    To Dr. Kayar: what kind of breast cancer markers are currently used to judge malignancy in case of stage null cases? I am asking this because I feel serious communication gap between experiencedTo Dr. Kayar: what kind of breast cancer markers are currently used to judge malignancy in case of stage null cases? I am asking this because I feel serious communication gap between experienced medical teams with research communities.We need to go for stage I-III trials for various therapeutic applications on which we are getting result in vivo in research, provided we know clearly, which one is currently being used by medical community in which stage of cancer and what is the statistics of 5-year survival in those patients.

    6 days ago

• Post protected

  Join ResearchGate now to read this post.
• Gian Paolo Andreoletti

  Senology Newsletter - February 7, 2012 - Latest Advances in Clinical Senology and Oncology. Share your comments and opininions http://www.senology.org/newsletter/Newsl_Feb2012.htm
• Gian Paolo Andreoletti

  Tyrosine kinase inhibitors reverse multidrug resistance and enhance the efficacy of conventional chemotherapeutic drugs http://www.cjcsysu.cn/cn/onlinef/AOP11-315.pdf
• Gian Paolo Andreoletti

  New fluid phase biopsy approach that identifies circulating tumor cells and presents them in sufficiently high definition to satisfy diagnostic pathology image qualityNew fluid phase biopsy approach that identifies circulating tumor cells and presents them in sufficiently high definition to satisfy diagnostic pathology image quality requirements http://iopscience.iop.org/1478-3975/9/1/016003 http://iopscience.iop.org/1478-3975/9/1/010301
• Gian Paolo Andreoletti

  Association of statins and taxanes: triggers cancer cell apoptosis http://is.gd/4osRLv
• Njoga Njihia

  Approach to linking breast cancer phenotypes to genetic variations

  Hello! Am new to the foray of clinical genetics and I was wondering if I could get help on any of the following: a. Which genetic mutations in sporadic breast cancer have been shown to have theHello! Am new to the foray of clinical genetics and I was wondering if I could get help on any of the following: a. Which genetic mutations in sporadic breast cancer have been shown to have the greatest potential for clinical application? b. What would be the best model to pursue for a cohort of patients: target specific polymorphisms or do genome-wide screening? c. Which samples would derive greatest utility with regards to durability and yield? ie urine, blood, paraffin-embedded tissue

  Recent replies ⋅ Show All (9)

  • 
    ragıp Kayar replied

    dear friend, If you present an outlined and prepared scenario for peer-reviewing, I might suggest you to read recent works on PUBMED.

    22 days ago
• Gian Paolo Andreoletti

  Vaccination with an anti-HER2 dendritic cell vaccine in women with early breastVaccination with an anti-HER2 dendritic cell vaccine in women with early breast cancer http://journals.lww.com/immunotherapy-journal/Abstract/2012/01000/A_Novel_Dendritic_Cell_based_Immunization_Approach.6.aspx
• Isabel Bong

  How many of you,use Field in Field technnique for Breast-Cancer Treatment and what about the QA?

  I have been doing research about this tecnnique for breast cancer treatment. The DVH results apparently are very good, less dose to OAR, less maximun dose to the skin,and max. PTV etc. I have provenI have been doing research about this tecnnique for breast cancer treatment. The DVH results apparently are very good, less dose to OAR, less maximun dose to the skin,and max. PTV etc. I have proven it. However, physicians are very reserved and sometimes they prefer "the traditional". My task is not to convince them, but I would like to know how many of you use this technnique and what can you say about the QA. I have tested it with ArcCheck but for the moment, I'm having problems with the pass rate; I'm trying to discover what is the reason.

  Recent replies ⋅ Show All (3)

  • 
    SA Yoganathan replied

    Main concern for intensity modulation in breast is the respiratory motion. Though the respiratory induced uncertainties (point dose) are averaged out over the typical course of RT (famous articles byMain concern for intensity modulation in breast is the respiratory motion. Though the respiratory induced uncertainties (point dose) are averaged out over the typical course of RT (famous articles by Bortfeld et al and Yu et al), the spatial location of dose distribution will vary. This necessitates the importance of controlling these intra-fractional motions in high gradient dose delivery such as IMRT (both in forward and inverse). Hence high gradient delivery should be practiced along with Intra-fractional motion management techniques i.e. breath hold or gating or tracking. Regarding your pass rate problem, It may due to the difference in resolution of reference dose plane (TPS) and the Arc check device.

    23 days ago
• Gian Paolo Andreoletti

  New onco-plastic surgery technique for early breast cancer, with an incision made immediately below the inframammary fold

  http://www.senology.org/Edit_GerbasiD.htm What do you tink about this new technique?
• Dr. Syed Abdul Aziz

  Anybody working on the variation of Telomerase length in Benign and Malignant breast cancer archival tissues and can they want to share the protocol?

  Anybody working on the variation of Telomerase length in Benign and Malignant breast cancer archival tissues and can they want to share the protocol?
• Gian Paolo Andreoletti

  Bacterial Tumour Targeting

  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0030940
• Gian Paolo Andreoletti

  Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

  Http://www.pnas.org/content/early/2012/01/18/1018866109.abstract?sid=4dad0a43-0d8d-48d6-9bb3-fe6d4a393554